Search

everythinglearnresearchcommunity

for

Search:↓

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Finasteride may improve prostate cancer treatment outcomes.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

CEC levels may be a useful marker for predicting prostate cancer progression.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Gene variation affects prostate issues and hair loss.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Vitamin D may help regulate cholesterol and influence prostate cancer development.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

Certain drugs that block specific enzymes can help treat prostate diseases.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Overexpressing SSAT enzyme reduces prostate tumor growth in mice.

TMPRSS2 helps viruses enter cells and protects the prostate from inflammation-related cancer.